Jafron Biomedical Co.,Ltd. (300529.SZ)
CNY 30.04
(-0.07%)
CNY 30.04
(-0.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.54 Billion CNY | 2.4% |
| 2022 | 5.41 Billion CNY | 12.54% |
| 2021 | 4.81 Billion CNY | 49.54% |
| 2020 | 3.21 Billion CNY | 28.94% |
| 2019 | 2.49 Billion CNY | 21.57% |
| 2018 | 2.05 Billion CNY | 20.53% |
| 2017 | 1.7 Billion CNY | 30.97% |
| 2016 | 1.29 Billion CNY | 88.75% |
| 2015 | 688.67 Million CNY | 27.77% |
| 2014 | 539.01 Million CNY | 16.74% |
| 2013 | 461.72 Million CNY | 35.17% |
| 2012 | 341.57 Million CNY | 38.72% |
| 2011 | 246.24 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 5.85 Billion CNY | 5.6% |
| 2024 Q3 | 5.59 Billion CNY | 2.47% |
| 2024 Q2 | 5.45 Billion CNY | -6.76% |
| 2023 Q4 | 5.54 Billion CNY | 0.86% |
| 2023 FY | 5.54 Billion CNY | 2.4% |
| 2023 Q3 | 5.49 Billion CNY | -2.5% |
| 2023 Q2 | 5.63 Billion CNY | -5.54% |
| 2023 Q1 | 5.96 Billion CNY | 10.23% |
| 2022 Q2 | 4.85 Billion CNY | -4.79% |
| 2022 Q1 | 5.09 Billion CNY | 5.92% |
| 2022 FY | 5.41 Billion CNY | 12.54% |
| 2022 Q4 | 5.41 Billion CNY | 5.22% |
| 2022 Q3 | 5.14 Billion CNY | 6.06% |
| 2021 Q2 | 4.49 Billion CNY | 28.01% |
| 2021 FY | 4.81 Billion CNY | 49.54% |
| 2021 Q1 | 3.5 Billion CNY | 9.09% |
| 2021 Q3 | 4.45 Billion CNY | -0.78% |
| 2021 Q4 | 4.81 Billion CNY | 7.92% |
| 2020 Q2 | 2.72 Billion CNY | 0.44% |
| 2020 FY | 3.21 Billion CNY | 28.94% |
| 2020 Q1 | 2.71 Billion CNY | 8.79% |
| 2020 Q4 | 3.21 Billion CNY | 12.11% |
| 2020 Q3 | 2.86 Billion CNY | 5.25% |
| 2019 Q1 | 2.18 Billion CNY | 6.45% |
| 2019 Q2 | 2.19 Billion CNY | 0.68% |
| 2019 Q3 | 2.31 Billion CNY | 5.28% |
| 2019 Q4 | 2.49 Billion CNY | 7.75% |
| 2019 FY | 2.49 Billion CNY | 21.57% |
| 2018 FY | 2.05 Billion CNY | 20.53% |
| 2018 Q4 | 2.05 Billion CNY | 9.17% |
| 2018 Q3 | 1.87 Billion CNY | 4.64% |
| 2018 Q2 | 1.79 Billion CNY | -0.34% |
| 2018 Q1 | 1.8 Billion CNY | 5.88% |
| 2017 Q1 | 1.49 Billion CNY | 14.98% |
| 2017 FY | 1.7 Billion CNY | 30.97% |
| 2017 Q4 | 1.7 Billion CNY | 8.02% |
| 2017 Q3 | 1.57 Billion CNY | 3.68% |
| 2017 Q2 | 1.52 Billion CNY | 1.7% |
| 2016 FY | 1.29 Billion CNY | 88.75% |
| 2016 Q3 | 1.21 Billion CNY | 57.14% |
| 2016 Q2 | 775.33 Million CNY | 7.17% |
| 2016 Q1 | 723.46 Million CNY | 5.05% |
| 2016 Q4 | 1.29 Billion CNY | 6.69% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 688.67 Million CNY | 27.77% |
| 2015 Q4 | 688.67 Million CNY | 0.0% |
| 2015 Q2 | 595.86 Million CNY | 0.0% |
| 2014 FY | 539.01 Million CNY | 16.74% |
| 2013 FY | 461.72 Million CNY | 35.17% |
| 2012 FY | 341.57 Million CNY | 38.72% |
| 2011 FY | 246.24 Million CNY | 0.0% |